HIV Protease Inhibitors May Curb COVID-19 Risk : vimarsana.c

Certain drugs used to treat HIV may have a role in preventing SARS-CoV-2 infections, according to preliminary data that may help explain why people living with the condition have not appeared to be at higher risk for serious COVID-19 despite being generally more vulnerable to infections.

Related Keywords

France , Villeneuve Saint Georges , France General , Steve Nguala , European Congress , Intercommunal Hospital Center , Reuters , Clinical Microbiology , Covid 19 , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , Uman Coronavirus 229e , Cov 229e , Corona Virus , Ovid19 , Ovel Coronavirus Sars Cov 2 , Hiv Infection , Hiv Disease , Shiv , Protease Inhibitor , Atazanavir , Darunavir , Ipranavir , Rt Protease Inhibitor ,